Sep 01, 2021
Keystone Dental acquires Osteon Medical, raises $25m led by Nantahala
Accelmed Partners I portfolio company Keystone Dental Inc. announced the acquisition of Osteon Medical and the completion of a $25 million financing round led by Nantahala, with participation from Accelmed and Migdal Insurance.
Aug 30, 2021
CartiHeal to be acquired by Bioventus for $500 million
Accelmed Ventures portfolio company CartiHeal is being acquired by Bioventus for $350 million in upfront consideration and up to $500 million including earn-outs.
Aug 13, 2021
Robotic surgery co Memic agrees $1b valuation SPAC merger
Memic, a portfolio company of Accelmed, signed a definitive agreement for a SPAC merger with MedTech Acquisition Corporation (Nasdaq: MTAC) with an equity value at over $1 billion.
Aug 04, 2021
CartiHeal succeeds in clinical trial for cartilage treatment
CartiHeal released a study validating the clear clinical benefits of its Agili-C™ implant for the treatment of cartilage lesions in arthritic and non-arthritic joints. Accelmed was the first investor in CartiHeal.
Jul 12, 2021
Project MedTech Podcast
Managing Partner Dr. Uri Geiger spoke with Duane Mancini, M. Sc. for the Project Medtech podcast and discussed his background, Israel’s medical device space and what they look for in a company, among other things.
Jun 14, 2021
Five Questions with Accelmed Managing Partner Uri Geiger
Managing Partner Dr. Uri Geiger sat down for a Q&A with Sarah Pringle of PE Hub to discuss how Accelmed distinguishes itself from traditional private equity funds, its unique differentiators and more.
Jun 14, 2021
Accelmed Expands Senior Team With Two New Partners
Accelmed bolsters its leadership team with the addition of two industry veterans, Eric Tansky and Stephen Rubin as General Partner and Partner respectively, as well as adding Lewis Pell and Stanley Stern to its Executives Network.
Jun 10, 2021
Barron’s Webinar - The Healthtech Revolution - A Conversation with AccelMed's Dr. Uri Geiger
Managing Partner Dr. Uri Geiger sat down with Lauren R. Rublin and Nathan-Kazis for a discussion on developments in pharma and biotech investing, innovations in healthtech, or the intersection of healthcare and technology, private equity investing in the healthcare arena, and healthtech innovations in Israel.
Mar 22, 2021
Accelmed Partners Leads $40 Million Investment in MedMinder
Accelmed Partners Leads a $40 Million Investment in MedMinder, the leading fully-integrated, end-to-end pharmacy, medication adherence and connected care solution for elderly and polypharmacy patients.
Mar 17, 2021
Accelmed Partners Raises $400 Million to Invest in Commercial Stage HealthTech
Accelmed successfully closed its oversubscribed second fund at the Fund’s hard cap of $400 million, exceeding its original $300 million target.
Mar 16, 2021
Emerging healthtech investor Accelmed closes Fund II at $400m hard cap
Accelmed Fund II, unveiled in late 2019, wrapped up this month at its hard cap, 33 percent above an original target of $300 million, founder and managing partner Uri Geiger told Buyouts. Fund II is more than 3x the size of its predecessor, closed in 2016 at $130 million.